The Kazmira Ecosystem
Kazmira Therapeutics is the parent scientific and manufacturing platform supporting a regulated cannabinoid healthcare ecosystem. We operate distinct, purpose-built entities to ensure clarity, compliance, and scalability across the full lifecycle — from pharmaceutical-grade manufacturing to clinical access.
01
Kazmira Therapeutics
The scientific and manufacturing backbone. Responsible for API development, GMP production, research, governance, and partner enablement.
02
Kazmira Pharmacy
A state-licensed 503A compounding pharmacy responsible for preparing and dispensing prescription cannabinoid formulations pursuant to valid clinician prescriptions
03
Cope Now
An independent telehealth care platform providing clinician-guided evaluation and ongoing care, where prescription cannabinoid therapy may be considered by clinicians when appropriate.
What We Build
The Foundation for Regulated Cannabinoid Care
Manufacturing
Kazmira operates a pharmaceutical manufacturing facility in Colorado under cGMP and ICH Q7 standards. Our proprietary separation technologies support the production of high-purity, THC-free cannabinoid APIs intended for regulated clinical and research use.
Pharmacy Enablement
Kazmira supports the translation of pharmaceutical-grade cannabinoid science into compliant pharmacy operations. Through alignment with licensed 503A compounding pharmacies, we support the preparation and dispensing of prescription cannabinoid formulations pursuant to valid clinician prescriptions, while maintaining the quality and manufacturing infrastructure required for consistency and traceability.
Care Platform Enablement
Kazmira supports the infrastructure that allows clinician-guided care platforms to operate within regulated cannabinoid workflows. Through aligned but independent systems, we enable secure data exchange and operational continuity, without participating in patient care, prescribing, or clinical decision-making.
Manufacturing
Kazmira operates a pharmaceutical manufacturing facility in Colorado under cGMP and ICH Q7 standards. Our proprietary separation technologies support the production of high-purity, THC-free cannabinoid APIs intended for regulated clinical and research use.
Pharmacy Enablement
Kazmira supports the translation of pharmaceutical-grade cannabinoid science into compliant pharmacy operations. Through alignment with licensed 503A compounding pharmacies, we enable the preparation and dispensing of prescription cannabinoid formulations pursuant to valid clinician orders, while providing the quality and manufacturing infrastructure required for consistency and traceability.
Care Platform Enablement
Kazmira supports the infrastructure that allows clinician-guided care platforms to operate within regulated cannabinoid workflows. Through aligned but independent systems, we enable secure data exchange and operational continuity, without participating in patient care, prescribing, or clinical decision-making.
Why It Matters
The path from cannabinoid science to medicine is narrow and regulated. Kazmira exists to operate within that path responsibly. As healthcare systems, clinicians, and regulators evaluate cannabinoids in clinical settings, the limiting factor is no longer interest — it is infrastructure.
Compliant Operations
Pharmaceutical-grade manufacturing, compliant pharmacy operations, and clear system boundaries are required for cannabinoid care to function within modern healthcare standards. Kazmira focuses on building that foundation with the rigor, discipline, and boundaries required by modern healthcare.
Pharma-Grade at Every Step
Kazmira operates under ISO, cGMP, EPA, and applicable pharmacy regulations, with full material traceability, quality systems, and audit-ready regulatory transparency across the ecosystem.